{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:54:31Z","timestamp":1760784871289,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009054","name":"icddr,b","doi-asserted-by":"publisher","award":["ACT-00384"],"award-info":[{"award-number":["ACT-00384"]}],"id":[{"id":"10.13039\/501100009054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jneuroim.2020.577388","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T04:36:16Z","timestamp":1599626176000},"page":"577388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Glucocorticoid receptor gene polymorphisms in Guillain-Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"348","author":[{"given":"Avizit","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Khurshid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoma","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasel","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhahirul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2020.577388_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","article-title":"The Guillain-Barr\u00e9 syndrome: a true case of molecular mimicry","volume":"25","author":"Ang","year":"2004","journal-title":"W Trends Immunol."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0010","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1469-0691.2007.01765.x","article-title":"Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain\u2013Barr\u00e9 and reactive arthritis patients","volume":"13","author":"Ang","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0015","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1529-8027.2009.00216.x","article-title":"Effect of glucocorticoid receptor gene polymorphisms in Guillain-Barr\u00e9 syndrome","volume":"14","author":"Dekker","year":"2009","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0030","first-page":"2383 LP","article-title":"A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis","volume":"28","author":"Derijk","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0035","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/brain\/awy232","article-title":"Regional variation of Guillain-Barr\u00e9 syndrome","volume":"141","author":"Doets","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2020.577388_bb0040","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1016\/S0021-9258(20)89627-6","article-title":"The genomic structure of the human glucocorticoid receptor","volume":"266","author":"Encio","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.12.001","article-title":"Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barr\u00e9 syndrome","volume":"161","author":"Geleijns","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0050","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.4049\/jimmunol.177.6.4211","article-title":"Mannose-binding lectin contributes to the severity of Guillain-Barr\u00e9 syndrome","volume":"177","author":"Geleijns","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2007.07.008","article-title":"Genetic polymorphisms of macrophage-mediators in Guillain-Barr\u00e9 syndrome","volume":"190","author":"Geleijns","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0060","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barre syndrome: Clinicalassociations and outcome","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0065","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/acn3.50884","article-title":"Human leukocyte antigen- DQB1 polymorphisms and haplotype patterns in Guillain-Barr\u00e9 syndrome","volume":"6","author":"Hayat","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116908","article-title":"Association of matrix metalloproteinase-9 polymorphism with severity of Guillain-Barr\u00e9 syndrome","volume":"415","author":"Hayat","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0075","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/acn3.51072","article-title":"Fc-gamma IIIa-V158F receptor polymorphism contributes to the severity of Guillain-Barr\u00e9 syndrome","volume":"7","author":"Hayat","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0080","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2020.577388_bb0085","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial of prednisolone in acute polyneuropathy","volume":"312","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2020.577388_bb0090","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/WNL.0b013e3181cff735","article-title":"Axonal variant of Guillain-Barr\u00e9 syndrome associated with Campylobacter infection in Bangladesh","volume":"74","author":"Islam","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2020.577388_bb0095","doi-asserted-by":"crossref","first-page":"e43976","DOI":"10.1371\/journal.pone.0043976","article-title":"Guillain-Barr\u00e9 syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies","volume":"7","author":"Islam","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2020.577388_bb0100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/jns.12189","article-title":"Guillain-Barr\u00e9 syndrome in Bangladesh: validation of Brighton criteria","volume":"21","author":"Islam","year":"2016","journal-title":"JPNS"},{"key":"10.1016\/j.jneuroim.2020.577388_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192703","article-title":"FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barr\u00e9 syndrome","volume":"13","author":"Islam","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2020.577388_bb0110","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/acn3.744","article-title":"Toll-like receptor-4 299Gly allele is associated with Guillain-Barr\u00e9 syndrome in Bangladesh","volume":"6","author":"Jahan","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0115","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barr\u00e9 syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2020.577388_bb0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jns.2005.07.009","article-title":"Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA","volume":"239","author":"Kuijf","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0125","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain\u2013Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0130","series-title":"Annals of the new York Academy of Sciences","first-page":"179","article-title":"Clinical features associated with glucocorticoid receptor polymorphisms: An overview","author":"Manenschijn","year":"2009"},{"key":"10.1016\/j.jneuroim.2020.577388_bb0135","doi-asserted-by":"crossref","first-page":"W20","DOI":"10.1093\/nar\/gkh435","article-title":"BLAST: at the core of a powerful and diverse set of sequence analysis tools","volume":"32","author":"McGinnis","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078699","article-title":"Rates of serious intracellular infections in autoimmune disease patients receiving initial glucocorticoid therapy","volume":"8","author":"Migita","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2020.577388_bb0145","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/ar3118","article-title":"Polymorphisms in the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis","volume":"12","author":"van Oosten","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0150","doi-asserted-by":"crossref","first-page":"W163","DOI":"10.1093\/nar\/gkn198","article-title":"IDT SciTools: a suite for analysis and design of nucleic acid oligomers","volume":"36","author":"Owczarzy","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577388_bb0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","article-title":"Electrophysiological diagnosis of Guillain\u2013Barr\u00e9 syndrome subtype: could a single study suffice?","volume":"86","author":"Rajabally","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2020.577388_bb0160","doi-asserted-by":"crossref","first-page":"1922 LP","DOI":"10.1128\/MCB.23.6.1922-1934.2003","article-title":"Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity","volume":"23","author":"Schaaf","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0165","article-title":"Gene section atlas of genetics and Cytogenetics in oncology and HaematologyNR3C1 (nuclear receptor subfamily 3, group C, member 1\/glucocorticoid receptor)","volume":"20","author":"Siamatras","year":"2016","journal-title":"Atlas Genet. Cytogenet. Oncol. Haematol."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0170","article-title":"Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition","author":"Van Rossum","year":"2006","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0175","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ando.2018.03.001","article-title":"Pathophysiology of glucocorticoid signaling","volume":"79","author":"Vitellius","year":"2018","journal-title":"Ann. Endocrinol. (Paris)."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0180","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1210\/jc.2008-2194","article-title":"A glucocorticoid receptor gene haplotype (TthIII1\/ER22\/23EK\/9\u03b2) is associated with a more aggressive disease course in multiple sclerosis","volume":"94","author":"van Winsen","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jneuroim.2020.577388_bb0185","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557282030446X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557282030446X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:38:42Z","timestamp":1759048722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557282030446X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":37,"alternative-id":["S016557282030446X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577388","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoid receptor gene polymorphisms in Guillain-Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577388"}}